It is generally assumed in the application of High Content Screening (HCS) that the cellular data exhibit a normal distribution. When a normal distribution exists, a well average approach to screening is possible. However, heterogeneity is a common attribute of cells and this can impact the design and implementation of a screen. A set of Heterogeneity indices (HI’s) have been developed to report out along with mean and standard deviations in screening/profiling data. Examples from drug discovery and drug development are presented.
Drug Discovery